New opportunities in drug design of metalloproteinase inhibitors: combination between structure––function experimental approaches and systems biology

Author： Sela-Passwell Netta   Trahtenherts Alla   Krüüger Achim   Sagi Irit  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.5, 2011-05, pp. : 527-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Structure-Function Based Drug Design for Cancer Therapeutics)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 14, 2016-11 ,pp. : 1200-1200

Bentham Science Publishers

Access to resources Recommend Favorite

The Design, Structure, and Therapeutic Application of Matrix Metalloproteinase Inhibitors

By  

Current Medicinal Chemistry, Vol. 8, Iss. 4, 2001-03 ,pp. : 425-474

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities for new protein crystallization strategies in structure-based drug design

By Grey Jessica Lynn   Thompson David H  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 11, 2010-11 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite

Metalloproteinase inhibitors: new opportunities for the treatment of rheumatoid arthritis and osteoarthritis

By Shaw T.   Nixon J.S.   Bottomley K.M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1469-1478

Informa Healthcare

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite